Supernus Pharmaceuticals Inc. logo

Supernus Pharmaceuticals Inc. (SUPN)

Market Closed
8 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
47. 16
+1.48
+3.24%
$
2.55B Market Cap
64.88 P/E Ratio
0% Div Yield
919,031 Volume
2.16 Eps
$ 45.68
Previous Close
Day Range
45.75 47.26
Year Range
29.16 57.65
Want to track SUPN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 78 days
Name Time Cons. EPS Eps
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
3 Mar 2026 (In 2 months)
0.41
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
24 Feb 2026 (In 2 months)
0.41
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
11 Nov 2025
0.14
0.61
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
4 Nov 2025
0.14
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
3 Nov 2025
0.3
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
31 Jul 2025
0.48
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
6 May 2025
0.38
0.44
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
25 Feb 2025
0.52
0.55
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
6 Nov 2024
0.44
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
6 Aug 2024
0.31
0.36
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
23 May 2024
0.38
0.46
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
8 May 2024
0.38
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
27 Feb 2024
0.55
0.89
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
8 Nov 2023
0.08
0.24
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
13 Dec 2016
0.34
0.37
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
2 Aug 2016
0.13
0.18
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
3 May 2016
0.09
0.08
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
2 Mar 2016
0.06
0.14
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
3 Nov 2015
0.02
0.08
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
4 Aug 2015
0.02
0.03
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
5 May 2015
-
0.02
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
10 Mar 2015
-
0.1
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
11 Nov 2014
0.36
0.39
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
11 Aug 2014
-
0.08
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
12 May 2014
-
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
12 Mar 2014
-
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
12 Nov 2013
-
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
13 Aug 2013
-
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
13 May 2013
-
-
Supernus Pharmaceuticals Inc. logo
SUPN Supernus Pharmaceuticals Inc.
14 Mar 2013
-
-

SUPN Earnings Reports FAQ

What is the earnings per share (EPS) for SUPN?

The current EPS is 2.16.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 20.24%, reflecting the SUPN's performance and NASDAQ (NMS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-24, based on the SUPN's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 0.6077 per share, reported on 2025-11-11. For dividend history, visit the SUPN Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 77.60, calculated based on the most recent stock price of $47.16.